Novo and Lundbeck-backed Acacia Pharma has postponed a $230m initial public offering in London as the healthcare IPO market continues to slow.

Biotech startups and spinouts in Cambridge, Massachusetts are set to receive $150m boost as fund aims for close.

Tai Diagnostics, a life sciences firm developing tests for transplanted organs, raises $8.2m.

Two years after leaving the financial services provider's corporate venturing unit, David Orlandella has returned to Orix Ventures as managing director.

The clinical testing services startup has secured funding in a round co-led by Qualcomm and Novartis vehicle dRx Capital.

Sanofi's corporate venturing subsidiary returned to back a $25m round for drug delivery system company Portal Instruments, closed a year after its $11m series A.

Sanofi's corporate venturing subsidiary returned to back a $25m round for drug delivery system company Portal Instruments, closed a year after its $11m series A.

Collective Health, the developer of a health insurance platform for enterprises, has now raised $119m and will expand out of California next year.